| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |